ENTITY
Illumina Inc

Illumina Inc (ILMN US)

54
Analysis
Health CareUnited States
Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
more
Refresh
07 Feb 2021 08:56

New Horizon IPO: Only Undemanding Assumptions Needed

We think the proposed valuation of New Horizon Health's (NHH HK) IPO is reasonable using undemanding assumptions and would participate in the...

Share
26 Nov 2020 21:49
Smartkarma Originals

Asian Healthcare - Coming of Age

This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...

Share
06 Nov 2020 09:55

Insights on China Genetic Testing Industry

This article analyzed China genetic testing industry in the perspective of favorable policy, market potential, future trend, investment trend in...

Logo
366 Views
Share
04 Jun 2020 11:17

Burning Rock (燃石医学) Pre-IPO: Thoughts on Valuation

Burning Rock, a leading precision oncology player in China, is aiming to raise USD 100 million via a listing in the US. The company is the number...

Logo
480 Views
Share
bullishVenture Corp
10 Dec 2019 13:24

Venture Corp (VMS SP): Next M&A Target in 2020?

Last month KKR raised a record 12.5B USD for a new Asian buyout fund. Slightly lower amounts, but still jointly totaling billions, were raised by...

Logo
865 Views
Share
x